Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma
β Scribed by Ke Wang; Chun-Tao Liu; Yong-Hong Wu; Yu-Ling Feng; Hong-li Bai
- Publisher
- Springer Healthcare Communications
- Year
- 2008
- Tongue
- English
- Weight
- 493 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0741-238X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Angiogenesis, the formation of new blood vessels, is controlled by a balance between positive and negative endothelial regulatory factors. Soluble vascular endothelial growth factor receptorβ1 (sVEGFR1), a naturally occurring soluble form of VEGFR1, is a negative counterpart of the vasc
The immunolocalization and gene expression of vascular endothelial growth factor (VEGF) and its cognate tyrosine kinase receptors, Flt-1 and KDR, has been studied in ocular melanomas and retinoblastomas using in situ hybridization and immunohistochemistry. Tumour-related alterations in VEGF/VEGF-rec
The formation of new vessels (angiogenesis) is essential for primary tumour growth and metastasis and is induced by several angiogenic factors, including vascular endothelial growth factor (VEGF). The microvascular density (MVD) in tumours was assessed and the expression of VEGF and its receptors VE